Nouscom appoints Göran Ando MD as Chairman and Richard Davis PhD as Chief Business Officer
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized genetic cancer vaccines, today announces that it has appointed Göran Ando, MD as the new Chairman of its Board of Directors. Nouscom also appointed Richard Davis, PhD as Chief Business Officer (CBO).
Dr. Guido Magni, former Chairman and Director of the Board, said: "I am delighted to welcome Dr. Ando, an experienced biopharmaceutical executive, to the company. It has been a plea...